Is RGNX stock safe? | Glauxie AI

Q: Is RGNX stock safe?

REGENXBIO Inc. (RGNX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Curran Simpson. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce... Employees: 200,000.

Q: What are the risks of investing in RGNX?

Identify key risks of investing in RGNX — debt, competition, volatility, and sector headwinds.

Q: Is RGNX a good long-term investment?

Evaluate RGNX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does RGNX have?

Review RGNX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is RGNX stock safe?

🦉

REGENXBIO Inc. (RGNX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCurran Simpson

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates...

Key Executives

Name	Title
Craig Malzahn	Executive Vice President of Product Development & Chief Technology Officer
Curran Simpson	President, Chief Executive Officer & Director
Jahannaz Dastgir	Clinical Development Lead
Mitchell Chan	Executive Vice President & Chief Financial Officer
Nina Hunter	SVP of Global Regulatory Strategy and Quality
Olivier Danos	Executive Vice President & Chief Scientific Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

RGNX Profile Financials

What are the risks of investing in RGNX? Is RGNX a good long-term investment? How much debt does RGNX have?